TrialJournal for immunotherapy of cancer2023

Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial.

Michelle V Dietz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.